Long Position on PRAH @ $24.10 on 12/31/2014 (Momentum)

PRA Health Sciences, Inc. (PRAH) is a clinical research organization.

The firm provides clinical trial solutions.

It engage in bioanalytical laboratory, clinical pharmacology, clinical development, strategic solutions, post marketing research, clinical informatics, clinical diagnostics, and safety and risk management activities.

The company offers therapeutic services in the areas of cardio-metabolic, biosimilars, infectious diseases, immunology, neurology and psychiatry, oncology and hematology, rare diseases, and respiratory needs.

It serves customers in North America, South America, the Middle East, Africa, the Asia-Pacific, and Europe. PRA Health Sciences, Inc. was formerly known as PRA International, Inc. and changed its name to PRA Health Sciences, Inc. in June 2014.

Shares of this recent IPO have formed a bullish "cup & handle" and higher share prices are expected for this stock.

Be Sure to Use a Limit Order!

52-Week Trading Range: $19.10 - $26.97

Entry Point: $24.10

Stop Loss: $22.89

Target Price: $26.51

Updates

1/22/2015 3:14:30 PM

PRAH closed at $27.85 after it exceeded our target price.

Position closed on 1/22/2015 at price of $27.85 with a 15.56% gain in 22 days.

Back to Portfolio